This evaluation was undertaken to supply precise and reliable detailed info
rmation to investigators actively working in carcinoid and related gynecolo
gical research fields.
A statistical evaluation was performed on 329 cases of ovarian carcinoid re
gistered in the Niigata Registry where world-wide information of gut-pancre
atic endocrinomas has been maintained by a computer-analyzing system. Cases
without individual identification or those recorded in groups were exclude
d. The evaluation was carried out mainly by a comparison between two groups
of cases with cystic teratoma/dermoid (Croup A) and those without such les
ions (Group B). The former group consisted of 189 cases (57.4%) and the lat
ter of 140 (42.6%).
Statistically significant differences between these two groups were recogni
zed in tumor size (44.7 mm vs 89.8 mm), rate of metastases (5.8% vs 22.1%),
rate of hepatic involvement (2.1% vs 15.0%), incidence of associated carci
noid syndrome (13.5% vs 22.9%) and 5-year survival rate (93.7% vs 84.0%). I
nsular type and trabecular type carcinoids were recorded at an almost equal
rate of one fourth ranging between 22% and 26% in either group. Another si
gnificant difference in the incidence of carcinoid syndrome was evident bet
ween the series of insular type and trabecular type carcinoids (38.9% vs 7.
8%).
The present evaluation on ovarian carcinoids disclosed definite, statistica
lly significant differences in various clinical and pathophysiologic aspect
s between Group A and Group B, as well as between insular type and trabecul
ar type histologic structures.